Science
Personalized Immunotherapy Response Studied in Body-on-a-Chip Cancer Models – Newswise
Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform…
Newswise — WINSTON-SALEM, NC, JULY 19, 2021 — Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest…
Continue Reading
-
Noosa News23 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News5 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business10 hours agoFord CEO makes stunning prediction about artificial intelligence